Immunovant, Inc.
$39.90
-0.92 (-2.25%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +3.6%
- 3 Months
- +29.0%
- YTD
- +57.0%
- 1 Year
- +171.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 61.4%
- Largest decline max drawdown, since Aug 2025
- -17.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.91
Own IMVT?
See how IMVT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.